FDA
- Status: approved
A: Peg-interferon alpha-2a & Ribavirin (A: Peg-interferon alpha-2a & Ribavirin) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Kaohsiung Medical University Chung-Ho Memorial Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.